Biological Markers in PD
Biological Markers in PD
Related Content
The Components of GP2’s Fifth Data Release
By Hampton Leonard, Mike A. Nalls, Dan Vitale, Mathew Koretsky, Kristin Levine, Mary B. Makarious, and Zih-Hua Fang | Complex Disease Genetics, Research Collaboration, Research Operations |
This release includes 7,462 additional new complex disease participants and 487 new monogenic disease participants, adding to the previous…
GP2 Visits India
By Sumit Dey, Alastair Noyce, Maria Teresa Periñan Tocino, Justin C. Solle, Mary B. Makarious, Brian Fiske, Kishore Raj Kumar, Ai Huey Tan, and Huw Morris | GP2 Values, Research Collaboration, Underrepresented Populations |
GP2 recently visited India where study team members took advantage of the 8th Asian and Oceanian Parkinson’s Disease and…
Precision Medicine in Parkinson’s Disease: Past Lessons and New Frontiers
By Harneek Chohan | GP2 Values, Research Collaboration, Research Communication, Underrepresented Populations |
Members of the GP2 Trainee Network recently had the opportunity to attend a two-day conference called ‘Precision Medicine in…
